Dangerous interaction with nefazodone added to fluoxetine,desipramine,venlafaxine,valproate and clonazepam combination therapy

Baldessarini R.J. (1996) Drugs and the treatment of psychiatric disorders . In Hardmann JG , Limbird LE , Molinoff PB , Ruddon R W , Goodman Gilman A (eds), Goodman & Gilman's the pharmacological basis of therapeutics. McGraw Hill, New York

Harvey AT , Preskorn SH (1996) Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors.Part I. J Clin Psychopharmac 16: 273-285

Ketter TA , Flockhart DA , Post RM , Denicoff K. , Pazzaglia PJ , Marangell L.B. , George M.S. , Callahan AM (1995) The emerging role of cytochrome P450 3A in psychopharmacology . J Clin Psychopharmac 15: 387-398

Malik K. (1996) Nefazodone: structure, mode of action and pharmacokinetics . J Psychopharmac 10 (Suppl. 1): 1-4

Marcus R.N. (1996) Safety and tolerability profile of nefazodone. J Psychopharmac 10 (Suppl. 1): 11-17

McNamara JO (1996) Drugs effective in the treatment of the epilepsies . In Hardman JG , Limbird L E , Molinoff P B , Ruddon R W , Goodman Gilman A (eds), Goodman & Gilman's the pharmacological basis of therapeutics. McGraw Hill, New York

Nemeroff CB , Lindsay DeVane C. , Pollock BC (1996) Newer antidepressants and the cytochrome P450 system . Am J Psychiat 153: 311-320

Preskorn S.H. (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiat 54 (Suppl. 9): 14-34

Preskorn S.H. (1995) What is the message in the alphabet soup of cytochrome P450 enzymes? J Pract Psychiat Behav Hlth 1: 237-240

Richelson E. (1994) The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiat 55 (Suppl. A): 34-39

Sternbach H. (1991) The serotonin syndrome. AmJ Psychiat 148 : 705-713